D.B. Root & Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$851K Buy
3,480
+263
+8% +$61.3K 0.2% 77
2025
Q4
$666K Sell
3,217
-19
-0.6% -$3.76K 0.16% 88
2025
Q3
$600K Buy
3,236
+190
+6% +$32.6K 0.15% 93
2025
Q2
$465K Sell
3,046
-2,155
-41% -$331K 0.14% 109
2025
Q1
$863K Sell
5,201
-325
-6% -$50.9K 0.28% 64
2024
Q4
$799K Sell
5,526
-96
-2% -$14.9K 0.25% 72
2024
Q3
$911K Sell
5,622
-984
-15% -$157K 0.3% 61
2024
Q2
$966K Sell
6,606
-213
-3% -$31.7K 0.33% 60
2024
Q1
$1.08M Sell
6,819
-63
-0.9% -$10K 0.36% 72
2023
Q4
$1.08M Sell
6,882
-462
-6% -$70.8K 0.39% 75
2023
Q3
$1.14M Sell
7,344
-246
-3% -$40.6K 0.45% 62
2023
Q2
$1.26M Sell
7,590
-200
-3% -$32.3K 0.48% 54
2023
Q1
$1.21M Sell
7,790
-6,432
-45% -$1.04M 0.48% 58
2022
Q4
$2.51M Buy
14,222
+58
+0.4% +$10K 1.06% 19
2022
Q3
$2.31M Sell
14,164
-25
-0.2% -$4.23K 1.05% 20
2022
Q2
$2.52M Sell
14,189
-68
-0.5% -$12.1K 1.08% 18
2022
Q1
$2.53M Buy
14,257
+250
+2% +$42.5K 0.94% 21
2021
Q4
$2.4M Sell
14,007
-114
-0.8% -$18.7K 0.86% 23
2021
Q3
$2.28M Sell
14,121
-1,106
-7% -$189K 0.89% 23
2021
Q2
$2.51M Sell
15,227
-59
-0.4% -$9.77K 0.94% 21
2021
Q1
$2.51M Sell
15,286
-9
-0.1% -$1.46K 0.99% 19
2020
Q4
$2.41M Buy
15,295
+202
+1% +$29.8K 0.96% 21
2020
Q3
$2.25M Sell
15,093
-134
-0.9% -$19.8K 0.9% 17
2020
Q2
$2.14M Buy
15,227
+50
+0.3% +$7.29K 0.93% 18
2020
Q1
$1.99M Buy
15,177
+392
+3% +$55.6K 1% 17
2019
Q4
$2.16M Sell
14,785
-110
-0.7% -$14.9K 0.95% 20
2019
Q3
$1.93M Sell
14,895
-980
-6% -$129K 0.9% 22
2019
Q2
$2.21M Sell
15,875
-559
-3% -$77.4K 0.98% 19
2019
Q1
$2.3M Buy
16,434
+66
+0.4% +$8.84K 0.98% 18
2018
Q4
$2.11M Buy
16,368
+1,878
+13% +$262K 1.05% 19
2018
Q3
$2M Buy
14,490
+213
+1% +$28.3K 0.88% 20
2018
Q2
$1.73M Buy
14,277
+332
+2% +$41.4K 0.82% 24
2018
Q1
$1.79M Buy
13,945
+7,089
+103% +$958K 0.94% 19
2017
Q4
$958K Buy
+6,856
New +$955K 0.82% 38

Other funds holding JNJ

D.B. Root & Company's JNJ Position: Q1 2026 in Review

D.B. Root & Company increased its Johnson & Johnson (JNJ) stake by 8.2% in Q1 2026, buying an estimated $61.3K and bringing the position to 3,480 shares worth $851K. The position accounts for 0.2% of the portfolio, ranked #77.

D.B. Root & Company first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.53M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • D.B. Root & Company held 3,480 shares of Johnson & Johnson worth $851K as of Q1 2026.
  • D.B. Root & Company bought 263 Johnson & Johnson shares in Q1 2026, an estimated $61.3K.
  • Johnson & Johnson made up 0.2% of D.B. Root & Company's portfolio in Q1 2026, its #77 holding.
  • D.B. Root & Company first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • D.B. Root & Company's Johnson & Johnson position peaked at $2.53M in Q1 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on D.B. Root & Company's 13F filing for Q1 2026, filed 13 May 2026.